• Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19 

      Vasbinder A., Anderson E., Shadid H., Berlin H., Pan M., Azam T.U., Khaleel I., Padalia K., Meloche C., O’hayer P., Michaud E., Catalan T., Feroze R., Blakely P., Launius C., Huang Y., Zhao L., Ang L., Mikhael M., Mizokami-Stout K., Pennathur S., Kretzler M., Loosen S.H., Chalkias A., Tacke F., Giamarellos-Bourboulis E.J., Reiser J., Eugen-Olsen J., Feldman E.L., Pop-Busui R., Hayek S.S. (2022)
      OBJECTIVE Diabetes mellitus (DM) is a major risk factor for severe coronavirus disease 2019 (COVID-19) for reasons that are unclear. RESEARCH DESIGN AND METHODS We leveraged the International Study of Inflammation in ...